Major and minor salivary gland tumours.

Gemma Gatta, Marco Guzzo, Laura D. Locati, Mark McGurk, Franz Josef Prott

Research output: Contribution to journalArticlepeer-review

Abstract

Salivary glands carcinomas are very rare epithelial malignant tumors. In 2013 in Europe, 7800 new diagnoses were estimated, 8.5 2017) counts more than 20 malignant histotypes, this variety as well as the rarity of some of them needs a skilled pathologist for diagnosis. Surgery remains the mainstay of management followed by radiation in high-grade and high-risk pathological features cases. The intensity modulated radiotherapy (IMRT) should be preferred over conformational radiotherapy techniques as adjuvant and exclusive treatment in advanced cases. Particle radiotherapy (i.e. protons, carbon ions) can have a role in advanced/unresectable disease since it was proved to have better results over photons in loco-regional control both in adenoid cystic carcinoma and in other histotypes. Although chemotherapy is still the most frequent treatment for metastatic patients, several new compounds (i.e. anti-angiogenic agents, tailored agents, checkpoint inhibitors) are under investigation.
Original languageEnglish
JournalCritical Reviews in Oncology/Hematology
Publication statusPublished - Aug 1 2020

Fingerprint Dive into the research topics of 'Major and minor salivary gland tumours.'. Together they form a unique fingerprint.

Cite this